Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Shorts have been at work! Thanks to Philippe for providing!
12/15/2022 117,333 11.55 343,895 1 No No
11/30/2022 105,184 -2.15 300,584 1 No No
11/15/2022 107,493 -9.97 115,340 1 No No
10/31/2022 119,400 9.40 119,600 1 No No
10/14/2022 109,143 5.92 463,562 1 No No
09/30/2022 103,043 -6.16 195,368 1 No No
09/15/2022 109,806 -6.27 89,023 1.23 No No
08/31/2022 117,155 2.68 229,174 1 No No
08/15/2022 114,102 -18.66 259,166 1 No No
07/29/2022 140,285 5.47 262,974 1 No No
$5-$10+
MERRY CHRISTMAS BOARD!
Simply Blessed to be alive!
rod
$5-$10+
Interesting UEEC could have just sold 50000 shares to White-Lion Capital LLC?
$5-$10+
12500 block just fell and more to come! News before eoy!
$5-$10+
Soon you will be able to check for an FDA PMA approval status here so save this link and simply enter the PMA number and device Hemostyp Gauze.
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm
Time for the pps to run before eoy!
$5-$10+
Here is the update!
United Health Products Provides Update on Manufacturing and FDA PMA Application
8:30 AM ET 12/19/22 | GlobeNewswire
United Health Products Provides Update on Manufacturing and FDA PMA Application
MESQUITE, NV, Dec. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company's FDA Premarket Approval application.
UHP continues to advance its Premarket Approval application with the Food and Drug Administration. The company has received and reviewed external laboratory test results on HemoStyp hemostatic gauze produced under its new manufacturing arrangements. The measured physical and chemical characteristics of the new product were shown to be effectively identical to those of the HemoStyp gauze product utilized in the company's human trial, a key step toward demonstrating a supply of equivalent product for planned commercial production. The company will now incorporate these laboratory results and other data into its PMA application for submission as soon as possible. Concurrently with these final steps for completion of its application, UHP continues to engage with the FDA on various technical aspects of its review process.
JMO but UEEC will decide to pursue a partnership production agreement upon FDA approval. Funding and sale of share to White Capital LLC may be necessary for the maximum possible buyout and require certain milestones be achieved. All for the purpose of obtaining the highest buyout pps.
$5-$10+
$5-$10+
Oh and the convertible note of $93000 has a nice (almost guaranteed) conversion to the lower price so I see your point. Not a bad option if the pps dropped as it did. Good point although in the technical sense not a bond. Interesting and maybe an investment from Doug the previous CEO? JMO!
$5-$10+
Thanks Band Aid and I share your opinion. Just waiting for a company pr to bring us up to date! Don't rely on others opinion of the timeline they have been more then incorrect in their opinion.
$5-$10+
FWIW interesting that Pfizer had a "GELFOAM PLUS HEMOSTASIS KIT" way back in
2009? So the FDA has some serious questions to require of supplements!
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=N18286S018
BTW Baxter was the third party in this case..."TO BE MANUFACTURED AND SUPPLIED BY BAXTER HEALTHCARE CORPORATION." So what happened?
$5-$10+
Reasonable for any investor to send the company a request for an FDA update!
$5-$10+
Your spot on! Slam dunk Hemostyp Gauze vs Surgicel!
https://www.clinicaltrials.gov/ct2/show/results/NCT03654560?term=hemostyp&rank=1
$5-$10+
Are the noted company's technology FDA approved?
STILLABELIEVER$$
$.10+
There is light at the end of the tunnel!
https://uhpcorp.com/about-us/
"The well-advanced application to the FDA for Premarket Approval (“PMA”) of HemoStyp® as a Class III medical device that would allow the gauze to be used for internal bleeding during human surgical procedures is nearing completion. The FDA’s review is ongoing. In anticipation of this approval, we are developing an expanded line of formats, including a flowable gel and powder, to cover the full range of surgical applications."
$5-$10+
Per the recent 10-Q
"In anticipation of receiving a Class III PMA (which cannot be assured), we are evaluating paths to rapidly grow our revenue and profits in all potential market segments, with the objective of maximizing shareholder value. Options under consideration include (i) a sale or merger of the Company with an industry leader in the wound care and surgical device sectors, which may include a pre-sale collaboration on commercialization and distribution, (ii) one or more commercial partnerships with established market participants, without any specific, associated sale or merger transaction, and (iii) a capital raising program to establish and grow our own marketing and distribution capabilities and drive revenue and profits organically.
$5-$10+
I believe he still holds shares in the company. He is just no longer contracted with UEEC.
$5-$10+
Thanks to Philiipe Niemetz for keeping us up on short interest in UEEC!
11/15/2022 107,493 -9.97 115,340 1 No No
10/31/2022 119,400 9.40 119,600 1 No No
10/14/2022 109,143 5.92 463,562 1 No No
09/30/2022 103,043 -6.16 195,368 1 No No
09/15/2022 109,806 -6.27 89,023 1.23 No No
08/31/2022 117,155 2.68 229,174 1 No No
08/15/2022 114,102 -18.66 259,166 1 No No
07/29/2022 140,285 5.47 262,974 1 No No
07/15/2022 133,005 -8.33 303,439 1 No No
06/30/2022 145,085 18.95 312,762 1 No No
Trending down!
$5-$10+
STILLABELIEVER$
Long and strong!
$.10+
Very little revenue and delays in FDA approval will answer your question!
$5-$10+
We may be seeing funding and the entry point for White Lion Capital ?
"HemoStyp samples produced under its new manufacturing arrangement."
https://uhpcorp.com/index.php/2022/09/06/united-health-products-announces-equity-financing-agreement-and-provides-corporate-update/
https://www.whitelioncapital.com/
"The proceeds of any sale of common stock to White Lion will be used for general corporate purposes including the establishment of a manufacturing operation for the company’s HemoStyp hemostatic gauze product and the completion of all remaining elements of the FDA Premarket Approval application, and to advance the development of powder and gel formats of the company’s patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent."
$5-$10+
https://uhpcorp.com
Looks like our new look website is an announcement of more to come!
"What Medical Professionals are saying about"
HemoStyp® Trauma Gauze
Newbies get updated on the company history here:
https://uhpcorp.com/index.php/news/
$5-$10+
Nice job noticing and posting this, Very forward looking!!!!
"What Medical Professionals are saying about
HemoStyp® Trauma Gauze"
$5-$10+
Looking at the FDA the request to UEEC would require an independent third party to analyze the Hemostyp gauze sample and then issue a certified analysis not only for the FDA reply but
also for our future customers or buyout party! Imo this will certainly strengthen a pps buyout!
$5-$10+
A highlight of the pr...... "the company has completed its review and documentation of manufacturing and packaging related Standard Operating Procedures (SOPs) and is now awaiting external laboratory test results on HemoStyp samples produced under its new manufacturing arrangement. Upon receipt and review of the sample analysis, the company expects to submit its full PMA application within a few days." Apparently we have a contract in place IMO to provide the FDA with our production sustainability as well to customer's in line who are ready to merge, buyout or sign distribution contracts!
$5-$10+
Progress.........
Mesquite, NV, Nov. 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provides an update on the company’s FDA Premarket Approval application. UHP continues to advance its Premarket Approval application with the Food and Drug Administration. As described in its October 31 press release, the company has completed its review and documentation of manufacturing and packaging related Standard Operating Procedures (SOPs) and is now awaiting external laboratory test results on HemoStyp samples produced under its new manufacturing arrangement. Upon receipt and review of the sample analysis, the company expects to submit its full PMA application within a few days. There can be no assurance that the company’s PMA application will be approved.
$5-$10+
Hey man watch that pps go up and you will regret cheap talk and no money to invest!
Ha Ha! Have a Happy Thanksgiving and your humor is funny!
$5-$10+
Hope you are correct? Doubtful that UEEC management will issue a pr or other notice of the FDA reply to the PMA submission but IMO the proposed submission date from the latest PR should give the pps a lift! Watch the pre-market? Keep Quantum on your radar!
$5-$10+
The sad thing is when the FDA approval is granted and those who own no shares are the real LOSERS! How about an update tomorrow?
$5-$10+
Lets see a happy thanksgiving for UEEC investors upon submission of the FDA reformatted PMA application and data requested. JMO that merger and acquisitions will soon be on UEEC's thanksgiving table! "The company expects to complete these tasks and work with its FDA consultant to draft and submit a revised application that is fully responsive to the Administration’s earlier comments, prior to November 22nd."
Happy Thanksgiving board!
$5-$10+
Some of us will recall that $2 per share had been offered at one time so your overly optimistic.
Hope I’m wrong but $5 would be sweet or let’s just go it alone with our production partner who’s is ready to go IMO!
$5-$10+
Good advice. Do your d/d!
STILLABELIEVER!
Optimism abodes IMO! Website has been modified and now presents a better pictorial view of the company!
"The increase in other income is due to the Company having received $392,000 as a litigation settlement payment from its former auditor and the receipt of $202,200 in cash and 2,085,258 shares of common stock as payment of $808,781 from its former Chief Executive Officer to satisfy a disgorgement obligation."
So to boot the company was able to retire 2,085,258 shares (Non-dilutive) to then be used for sale to White Lion Capital, LLC
$5-$10++
Not sure how positive the news is but certainly Brian Thom has a million dollar invested as well so we all have not come this far for naught! Lets see some commercial revenue in the 10Q and look for a partnership with a manufacturing concern!
Happy Veterans Day to all who have served the USA!
$5-$10++
Waiting for the 10Q to come out today after hours or Monday morning may reveal commercial business ramping up? According to our CEO Brian Thom before the 14th!
"Separately, UHP expects to file its financial report for the third quarter of 2022 on Form 10-Q no later than November 14th. The report will show that the company generated modest commercial revenue for the first time since 2019, reflecting its reengagement with customers in the U.S. 510k market as well in certain international markets."
$5-$10++
Eye on the prize! Its all about validation support!
https://www.rcainc.com/medical-device/remediation-strategy-and-support/manufacturing-and-facility-validation/
$5-$10++
Hold the line!!!
SHORT INTEREST
DATE SHORT INTEREST % CHANGE AVG. DAILY SHARE VOL DAYS TO
COVER SPLIT NEW ISSUE
10/31/2022 119,400 9.40 119,600 1 No No
10/14/2022 109,143 5.92 463,562 1 No No
09/30/2022 103,043 -6.16 195,368 1 No No
09/15/2022 109,806 -6.27 89,023 1.23 No No
08/31/2022 117,155 2.68 229,174 1 No No
08/15/2022 114,102 -18.66 259,166 1 No No
07/29/2022 140,285 5.47 262,974 1 No No
07/15/2022 133,005 -8.33 303,439 1 No No
06/30/2022 145,085 18.95 312,762 1 No No
06/15/2022 121,967 2.78 389,559 1 No No
$5-$10+
Thanks for your post and info. FDA takes all the time they need plus their new medical device system guidelines which IMO have created a need for a webinar seemingly to resolve inquiries? Just a thought that our medical device PMA seems to parallel the FDA timeline? Coincidence or not?
$5-$10++